4.6 Article

SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors-1α and-2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets

期刊

CANCERS
卷 11, 期 12, 页码 -

出版社

MDPI
DOI: 10.3390/cancers11121933

关键词

SerpinB3; hypoxia; hypoxia inducible factors HIF-1 alpha and HIF-2 alpha; HCC; NEDD8; NEDDylation

类别

资金

  1. Italian Ministero dell'Universita e della Ricerca (MIUR, Rome: PRIN Project) [2006067527]
  2. Fondazione CRT (Torino)
  3. Associazione Italiana per la Ricerca sul Cancro (AIRC) [20361]
  4. University of Padova [CPDA110795]
  5. University of Torino
  6. Gobierno Vasco-Departamento de Salud [2013111114]
  7. EITB Maratoia [BIO15/CA/014]
  8. Asociacion Espanola contra el Cancer
  9. MINECO [SEV-2016-0644]
  10. [SAF2017-87301-R]

向作者/读者索取更多资源

Background: SerpinB3 (SB3) is a hypoxia and hypoxia-inducible factor (HIF)-2 alpha-dependent cysteine-protease inhibitor up-regulated in hepatocellular carcinoma (HCC), released by cancer cells and able to stimulate proliferation and epithelial-to-mesenchymal-transition. Methods: In the study we employed transgenic and knock out SerpinB3 mice, liver cancer cell line, human HCC specimens, and mice receiving diethyl-nitrosamine (DEN) administration plus choline-deficient L-amino acid refined (CDAA) diet (DEN/CDAA protocol). Results: We provide detailed and mechanistic evidence that SB3 can act as a paracrine mediator able to affect the behavior of surrounding cells by differentially up-regulating, in normoxic conditions, HIF-1 alpha and HIF-2 alpha. SB3 acts by (i) up-regulating HIF-1 alpha transcription, facilitating cell survival in a harsh microenvironment and promoting angiogenesis, (ii) increasing HIF-2 alpha stabilization via direct/selective NEDDylation, promoting proliferation of liver cancer cells, and favoring HCC progression. Moreover (iii) the highest levels of NEDD8-E1 activating enzyme (NAE1) mRNA were detected in a subclass of HCC patients expressing the highest levels of HIF-2 alpha transcripts; (iv) mice undergoing DEN/CDAA carcinogenic protocol showed a positive correlation between SB3 and HIF-2 alpha transcripts with the highest levels of NAE1 mRNA detected in nodules expressing the highest levels of HIF-2 alpha transcripts. Conclusions: These data outline either HIF-2 alpha and NEDDylation as two novel putative therapeutic targets to interfere with the procarcinogenic role of SerpinB3 in the development of HCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

Maria Juarez-Fernandez, Naroa Goikoetxea-Usandizaga, David Porras, Maria Victoria Garcia-Mediavilla, Miren Bravo, Marina Serrano-Macia, Jorge Simon, Teresa C. Delgado, Sofia Lachiondo-Ortega, Susana Martinez-Florez, Oscar Lorenzo, Mercedes Rincon, Marta Varela-Rey, Leticia Abecia, Hector Rodriguez, Juan Anguita, Esther Nistal, Maria Luz Martinez-Chantar, Sonia Sanchez-Campos

Summary: This study provides evidence for the relevance of the interaction between mitochondria and microbiota in NASH and identifies targeting this interaction as a valuable therapeutic approach.

HEPATOLOGY (2023)

Article Multidisciplinary Sciences

Hyperphosphorylation of hepatic proteome characterizes nonalcoholic fatty liver disease in S-adenosylmethionine deficiency

Aaron E. Robinson, Aleksandra Binek, Komal Ramani, Niveda Sundararaman, Lucia Barbier-Torres, Ben Murray, Vidya Venkatraman, Simion Kreimer, Angela Mc Ardle, Mazen Noureddin, David Fernandez-Ramos, Fernando Lopitz-Otsoa, Virginia Gutierrez de Juan, Oscar Millet, Jose M. Mato, Shelly C. Lu, Jennifer E. Van Eyk

Summary: Methionine adenosyltransferase 1a (MAT1A) gene is responsible for the synthesis of hepatic S-adenosyl-L-methionine (SAMe). Deficiency of MAT1A results in hepatic SAMe depletion and development of nonalcoholic steatohepatitis (NASH), which can be reversed by SAMe administration. In this study, alterations in the proteome/phosphoproteome were examined in pre-disease and NASH Mat1a(-/-) mice, and compared to human nonalcoholic fatty liver disease (NAFLD). Common proteomic/phosphoproteomic signatures and metabolomic characteristics were found betweenMat1a(-/-) mice and a specific subtype of human NAFLD, suggesting potential implications for pathophysiology and therapy.

ISCIENCE (2023)

Review Biochemistry & Molecular Biology

Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses

Beatrice Foglia, Marc Beltra, Salvatore Sutti, Stefania Cannito

Summary: Hepatocellular carcinoma (HCC) is a common primary liver cancer, ranking third in cancer-related mortality worldwide. Metabolic rewiring has emerged as a key factor in HCC progression, affecting cancer cell behavior and immune responses. This review focuses on recent studies exploring HCC's metabolic traits, specifically alterations in glucose, fatty acid, and amino acid metabolism. Additionally, it examines how metabolic reprogramming can impact the tumor microenvironment and immune cell populations, enabling tumor escape from immunosurveillance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies

Anna Maria Tolomeo, Gaia Zuccolotto, Ricardo Malvicini, Giada De Lazzari, Alessandro Penna, Chiara Franco, Federico Caicci, Fabio Magarotto, Santina Quarta, Michela Pozzobon, Antonio Rosato, Maurizio Muraca, Federica Collino

Summary: This study aimed to evaluate the biodistribution of MSC-EVs after different routes of administration in mice. Results showed that local administration could increase the concentration of EVs in selective organs, limiting their systemic distribution and potentially reducing extra-organ effects. Biodistribution studies can help in selecting the most appropriate way of administering MSC-EVs for treating different diseases.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition

Alessandra Biasiolo, Michele Sandre, Stefania Ferro, Santina Quarta, Mariagrazia Ruvoletto, Gianmarco Villano, Cristian Turato, Maria Guido, Oriano Marin, Patrizia Pontisso

Summary: This study aimed to generate antibodies against different SerpinB3 epitopes to better understand their biological role. Five exposed epitopes were identified and corresponding synthetic peptides were used for rabbit immunization. Anti-P#2 and anti-P#4 antibodies could recognize both SerpinB3 and SerpinB4, while anti-P#5 antibody showed the greatest specific reactivity for human SerpinB3 and could recognize SerpinB3 at the nuclear level.

BIOMOLECULES (2023)

Article Biochemistry & Molecular Biology

Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice

Saadet Turkseven, Cristian Turato, Gianmarco Villano, Mariagrazia Ruvoletto, Maria Guido, Massimo Bolognesi, Patrizia Pontisso, Marco Di Pascoli

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can progress to non-alcoholic steatohepatitis (NASH) and eventually cirrhosis. Inflammation and oxidative stress, caused by mitochondrial dysfunction, are crucial in the development of NASH. This study evaluated the potential of acetylsalicylic acid (ASA) and mitoquinone, an antioxidant, to inhibit the progression of NASH. The results showed that both ASA and mitoquinone reduced liver steatosis and inflammation, restored anti-inflammatory factors, and increased antioxidant expression.

ANTIOXIDANTS (2023)

Article Biology

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness

Santina Quarta, Andrea Cappon, Cristian Turato, Mariagrazia Ruvoletto, Stefania Cannito, Gianmarco Villano, Alessandra Biasiolo, Maristella Maggi, Francesca Protopapa, Loris Bertazza, Silvano Fasolato, Maurizio Parola, Patrizia Pontisso

Summary: This study investigates the ability of SerpinB3 to modulate the Wnt pathway in liver cancer and monocytic cells, finding that SerpinB3 activates the Wnt signaling pathway and increases cell survival and invasiveness through the upregulation of Wnt co-receptors and LRP family members.

BIOLOGY-BASEL (2023)

Article Endocrinology & Metabolism

Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function

Maria J. Gonzalez-Rellan, Tamara Parracho, Violeta Heras, Amaia Rodriguez, Marcos F. Fondevila, Eva Novoa, Natalia Lima, Marta Varela-Rey, Ana Senra, Maria D. P. Chantada-Vazquez, Cristina Ameneiro, Ganeko Bernardo, David Fernandez-Ramos, Fernando Lopitz-Otsoa, Jon Bilbao, Diana Guallar, Miguel Fidalgo, Susana Bravo, Carlos Dieguez, Maria L. Martinez-Chantar, Oscar Millet, Jose M. Mato, Markus Schwaninger, Vincent Prevot, Javier Crespo, Gema Fruhbeck, Paul Iruzubieta, Ruben Nogueiras

Summary: O-GlcNAcylation is a post-translational modification that affects protein function and localization, and its deregulation is associated with various human diseases. This study reveals the role of O-GlcNAcylation in the progression of NAFLD, providing new avenues for therapeutic intervention.

MOLECULAR METABOLISM (2023)

Review Oncology

Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma

Pietro Guerra, Andrea Martini, Patrizia Pontisso, Paolo Angeli

Summary: Hepatocellular Carcinoma (HCC) is a common and aggressive cancer with limited treatment options. Immunotherapy has shown promising results in the treatment of human cancers, including HCC. However, the effectiveness of immunotherapy in HCC is limited, and the identification of new targets is crucial for improved outcomes.

CANCERS (2023)

Article Chemistry, Medicinal

1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2

Monica Chinellato, Matteo Gasparotto, Santina Quarta, Mariagrazia Ruvoletto, Alessandra Biasiolo, Francesco Filippini, Luca Spiezia, Laura Cendron, Patrizia Pontisso

Summary: In recent years, studies on the inflammatory signaling pathways have identified new targets for novel therapies. This research reveals that the small molecule 1-PPA can bind to PAR2 and exhibit antagonistic effects on its activity, potentially providing a promising new approach for the treatment of PAR2-related diseases.

PHARMACEUTICALS (2023)

暂无数据